Nurses’ and patients’ experiences and preferences of the Ankle-Brachial Pressure Index and Multi-site Photoplethysmography for the diagnosis of peripheral arterial disease: A qualitative study by Scott, Jason et al.
Northumbria Research Link
Citation: Scott,  Jason, Lecouturier,  Jan, Rousseau, Nikki,  Stansby, Gerard, Sims, Andrew, Wilson, 
Lesley  and  Allen,  John  (2019)  Nurses’ and  patients’ experiences  and  preferences  of  the  Ankle-
Brachial Pressure Index and Multi-site Photoplethysmography for the diagnosis of peripheral arterial 
disease: A qualitative study. PLoS ONE. ISSN 1932-6203 
Published by: Public Library of Science
URL: https://doi.org/10.1371/journal.pone.0224546 <https://doi.org/10.1371/journal.pone.0224546>
This version was downloaded from Northumbria Research Link: http://nrl.northumbria.ac.uk/41143/
Northumbria University has developed Northumbria Research Link (NRL) to enable users to access 
the University’s research output. Copyright © and moral rights for items on NRL are retained by the 
individual author(s) and/or other copyright owners.  Single copies of full items can be reproduced, 
displayed or performed, and given to third parties in any format or medium for personal research or 
study, educational, or not-for-profit purposes without prior permission or charge, provided the authors, 
title and full bibliographic details are given, as well as a hyperlink and/or URL to the original metadata 
page. The content must not be changed in any way. Full items must not be sold commercially in any  
format or medium without formal permission of the copyright holder.  The full policy is available online: 
http://nrl.northumbria.ac.uk/pol  i cies.html  
This  document  may differ  from the  final,  published version of  the research  and has been made 
available online in accordance with publisher policies. To read and/or cite from the published version 
of the research, please visit the publisher’s website (a subscription may be required.)
                        

Nurses’ and patients’ experiences and preferences of the Ankle-1 
Brachial Pressure Index and Multi-site Photoplethysmography for the 2 
diagnosis of peripheral arterial disease: A qualitative study 3 
 4 
Jason Scott1*, Jan Lecouturier2, Nikki Rousseau2*, Gerard Stansby3, 4,, Andrew Sims5, 6, Lesley Wilson3, 5 
John Allen5, 6 6 
 7 
1 Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom 8 
2 Institute of Health and Society, Newcastle University, Newcastle upon Tyne, United Kingdom 9 
3 Northern Vascular Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon 10 
Tyne, United Kingdom 11 
4 School of Surgical and Reproductive Sciences, Newcastle University, Newcastle upon Tyne, United 12 
Kingdom 13 
5 Northern Medical Physics and Clinical Engineering Department, Newcastle upon Tyne Hospitals NHS 14 
Foundation Trust, Newcastle upon Tyne, United Kingdom 15 
6 Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom 16 
 17 
*Corresponding authors 18 
Jason Scott 19 
jason.scott@northumbria.ac.uk  20 
 21 




Experiences and preferences of ABPI and MPPG 
Page 1 of 25 
 
Abstract 26 
Peripheral arterial disease is a global health problem, affecting around 20% of people aged over 60 27 
years. Whilst ankle-brachial pressure index (ABPI) is regularly used for diagnosis, it has a number of 28 
limitations, which have presented a need for alternative methods of diagnosis. Multi-site 29 
photoplethysmography (MPPG) is one such method, but evidence of acceptability of both methods is 30 
lacking. This study aims to describe and compare preferences and experiences amongst nurses and 31 
patients of ABPI and MPPG use in primary care. We used qualitative research methods in the context 32 
of a clinical diagnostic study comparing ABPI with MPPG. Use of ABPI and MPPG by 13 nurses were 33 
observed with 51 patients across general practice surgeries in North-East England in 2015/16. Follow-34 
up semi-structured interviews were conducted with 12 nurses and 27 patients. Data were thematically 35 
analysed. Two major themes were identified: (1) device preferences; (2) test discomfort and anxiety. 36 
There was a compelling preference for MPPG due to ease of use, speed of the test, patient comfort, 37 
and perceived device accuracy/objectivity. However some patients struggled to identify a preference, 38 
describing ambivalence to medical testing. ABPI was deemed uncomfortable and painful, particularly 39 
when the blood pressure cuff was inflated at the lower limbs. There was also evidence of anxiety 40 
amongst patients when their foot pulses were not identified using ABPI. Whilst ABPI is a non-invasive 41 
and routine procedure it was associated with a number of drawbacks in clinical practice. Nurses 42 
required considerable dexterity to employ the test, and it resulted in anxiety amongst some patients. 43 
Conversely, MPPG was deemed to be easier and quicker to use, and perceived to be less subjective. 44 
Should diagnostic accuracy and cost be comparable to ABPI, then the findings of this study suggest 45 
MPPG would be preferable to ABPI for patients as well as nurses. 46 
 47 
Introduction 48 
Peripheral arterial disease (PAD) is the restriction of blood flow in the arteries, typically in the lower 49 
extremities, the most common symptom of which is intermittent claudication (pain) [1 2], though PAD 50 
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can also contribute to functional impairment without intermittent claudication such as atypical 51 
exertional leg pain [2]. Other symptoms include ischaemic rest pain, ischaemic ulceration, and limb 52 
loss in the most extreme cases [3]. PAD is a global health problem, affecting around one in five people 53 
aged over 60 years [4]. People with PAD have been identified to have a significantly lower quality of 54 
life and high levels of pain [5], although PAD is often under-reported, under-diagnosed and sub-55 
optimally treated [6 7]. More specifically, the majority of people with PAD are asymptomatic [4] 56 
despite similar levels of mortality to symptomatic patients [8], and many of those patients who are 57 
symptomatic do not present to their general practitioner or other healthcare professional due to a 58 
lack of knowledge about PAD [9]. This is despite PAD being associated with a high risk of other vascular 59 
events such as heart attacks and strokes, as well as limb amputation and claudication [10 11].  60 
 61 
PAD can be diagnosed using various different methods; guidelines for the National Health Service 62 
(NHS) in England [12] include verbal communication of symptoms that indicate intermittent 63 
claudication and critical limb ischaemia, physical examination of legs and feet for evidence of critical 64 
limb ischaemia, examination of femoral, popliteal and foot pulses, measuring the ankle brachial 65 
pressure index (ABPI), or a duplex ultrasound arterial scan. Other methods include digital subtraction 66 
angiography [13], magnetic resonance angiography, and computed tomography angiography [14].  67 
 68 
Within primary care settings, ABPI is used often because it is able to be conducted by trained nursing 69 
staff, and it can demonstrate relatively high levels of accuracy [15]. ABPI works by measuring blood 70 
pressure non-invasively in the arteries which supply the lower extremities, typically at the level of the 71 
ankle, and comparing with blood pressures measured at the arm [16]. Recent evidence suggests that 72 
ABPI is a cost-effective method of screening for PAD as an indicator of cardiovascular risk [17] despite 73 
it being relatively time consuming due to a required ten minute rest period prior to testing. However, 74 
whilst ABPI is able to detect severe disease, it is less accurate at detecting mild or moderate disease 75 
[18]. ABPI is also liable to large variation in practice; the position of patient, order of limb 76 
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measurement and use of mean or maximum measurements in the ABPI calculation can all differ 77 
depending on the clinician conducting the test [19], possibly due to there being no standard approach 78 
to training [20]. Another explanation for variation in ABPI measurement is terminal digit preference, 79 
where clinicians have been identified to overuse specific digits, particularly the digit 0, when recording 80 
systolic and diastolic blood pressure test results [21].  81 
 82 
These limitations of ABPI suggest a need for alternative approaches to identifying and diagnosing PAD, 83 
with more novel ways of doing so currently being developed. One novel approach to diagnosing PAD 84 
utilizes multi-site photoplethysmography (MPPG) technology, which is a non-invasive and simple-to-85 
use test for PAD that measures how long it takes the patient’s pulse to reach different parts of their 86 
body. This is based on optical peripheral pulse waveform analysis, and demonstrates similar sensitivity 87 
and specificity in detecting PAD as ABPI [22-24]. However, due to its novelty, there is currently no 88 
published data on its usability or acceptance within primary care. ABPI and MPPG were chosen for 89 
comparison as ABPI is the standard approach to measuring PAD in primary care practice, and both 90 
approaches follow a similar process (see box).  91 
 92 
The aim of the study was to describe and compare nurses’ and patients’ experiences and preferences 93 
of ABPI and MPPG use in primary care. The study was situated in a larger clinical diagnostic study 94 
comparing ABPI with MPPG (see box for description of the wider study).  95 
 96 
To assess diagnostic accuracy of MPPG, patients with symptomatic PAD and an equal number of 
age-matched non-PAD patients were identified and recruited from general practice registers in the 
North East of England. A total of 306 patients were recruited into the trial and all study 
measurements were carried out in primary care. Informed consent was taken by a vascular research 
nurse who carried out a screen for PAD symptoms using the Edinburgh Claudication Questionnaire, 
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recorded the participant's height and weight to calculate BMI and recorded basic demographics and 
past medical history and medications. Study MPPG and ABPI measurements were then carried out 
by a practice nurse. All practice nurses had been previously trained in the two techniques by the 
study team. ABPI used as a comparator as it is deemed standard practice in primary care, and it was 
measured using standard methods as recommended by NICE guidelines [12]. Finally, a vascular 
scientist blinded to the ABPI and MPPG results carried a bilateral lower limb Duplex vascular 
ultrasound scan to act as a gold standard test for the presence of PAD.  
 
ABPI measurement process, adapted from National Institute for Health and Clinical Excellence [12] 
guidelines on diagnosing and managing PAD: 
 Patient should be lying down, following a rest period of ten minutes 
 Systolic blood pressure readings should be recorded for both arms and feet (posterior tibial, 
dorsalis pedis) using an appropriately sized cuff 
 Measurements taken manually using a Doppler ultrasound probe of suitable frequency in 
preference to an automated system 
 Calculate the index in each leg by dividing the highest ankle pressure by the highest arm 
pressure. 
 
MPPG measurement process (adapted from Allen et al. [23]) for Novel pulse device for diagnosis of 
PAD (NOTEPAD) diagnostic trial: 
 Patient should be lying down, following a rest period of ten minutes 
 Pulse probes clipped bilaterally to the ear lobes, index finger pads and great toe pads  
 Gains adjusted for a clear pulse obtained at each measurement site; the patient is asked to 
remain comfortably still throughout their measurement 
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 Pulses recorded for about a minute and the individual site MPPG Shape Index measures of 
PAD automatically and immediately calculated and displayed for the operator to note 
down. 
Box: Description of clinical diagnostic accuracy study, Novel pulse device for diagnosis of PAD 97 
(NOTEPAD), and comparison of measurement processes for ABPI and MPPG technology used in the 98 
study.  99 
 100 
Methods 101 
Qualitative design methods (semi-structured interviews and observations) were incorporated into the 102 
NOTEPAD study described in the box. Such an approach has the ability to develop a better 103 
understanding of factors that contribute to increased or decreased effectiveness of interventions in 104 
the real world [25]. Furthermore, it has been reported that embedded qualitative research in trials is 105 
able to provide insight into how trial participants experience the intervention [26]. In this study, the 106 
insight was extended beyond only patients receiving the intervention to also include nurses using ABPI 107 
and MPPG. The data is based on transcripts produced from audio recordings of interviews with 108 
research participants. We do not have consent to disseminate the full transcripts and we wish to 109 
respect the anonymity of the research participants. Restrictions on data sharing were in place 110 
following ethical review by NHS Research Ethics Committee North East – Newcastle & North Tyneside 111 
1 (ref: 14/NE/1238). However, relevant sections of the transcripts have been included in the 112 
manuscript to support our findings. Study materials are available as supplementary materials to 113 
enable replication, and we would be willing to interrogate the dataset on behalf of other studies upon 114 
reasonable request. Requests should be made to the study sponsor by emailing Angela Topping at 115 
nuth.nuthsponsorship@nhs.net.  116 
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 117 
Setting and sampling 118 
A convenience sample of nursing staff, including practice nurses and research nurses, from 16 primary 119 
care practices who were involved in the wider clinical diagnostic study (NOTEPAD) were invited to 120 
participate in semi-structured interviews. For observations, nursing staff and patients from nine 121 
practices were sampled based on their involvement in the NOTEPAD study. These nine practices were 122 
sampled as the team felt they provided diversity in terms of geographical spread. No practices 123 
declined to be observed. A convenience sample of patients who had been observed were also invited 124 
to participate in interviews based upon their participation in the NOTEPAD study and having been 125 
observed. This sample included patients previously diagnosed with PAD (case patients) who were 126 
recruited to the NOTEPAD study through local PAD registers (the Quality and Outcomes Framework 127 
[27] states that general practices should establish and maintain a register of patients with PAD (pages 128 
35-36)), and age-matched patients who had no diagnosis of PAD (control patients). Data collection 129 
(observations and interviews) was conducted up until data saturation (the point at which new data 130 
collection was not adding to or elaborating upon the themes identified in the analysis) was reached 131 
[28]. The number of interviews within each subgroup of participant (nurses, case patients and control 132 
patients) either meeting or exceeding the required number identified as being necessary for 133 
saturation [29]. 134 
 135 
Recruitment and consent 136 
Nurses conducting both ABPI and MPPG, which included practice nurses and research nurses, were 137 
invited to participate in semi-structured interviews and observations of the two tests in use. Nurse 138 
consent to be observed was obtained during recruitment to the diagnostic accuracy study. Nurse 139 
consent to participate in a semi-structured interview was obtained separately, either before or after 140 
observation.  141 
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 142 
Patients were recruited to take part in the observational component of the study by a research nurse 143 
prior to the patients’ appointments for the diagnostic accuracy study tests. Upon completion of both 144 
tests, patients were then given information about the semi-structured interview, and contacted a 145 
minimum of 48 hours later by a researcher to take consent. Interviews were only conducted with 146 
patients who had been observed undergoing the ABPI and MPPG tests. We did not collect details of 147 
people who declined to participate.  148 
 149 
Data collection 150 
Non-participant observations were conducted by two researchers (JS, male and KL, female) to explore 151 
nurses’ behaviours and responses when using ABPI and MPPG, and how patients responded to the 152 
tests. Researcher observations occurred within treatment rooms of the primary care practices and of 153 
training sessions for nurses on the use of ABPI and MPPG. Clinics consisting of morning or afternoon 154 
timeslots, with up to four patients per clinic, were held specifically for the purpose of the clinical 155 
diagnostic accuracy study. The majority of the clinics consisted of one nurse conducting the tests, but 156 
on some occasions there were two nurses. Prior to the start of the clinic, the researcher would present 157 
to the nurse(s) and agree where to be positioned within the treatment room so to cause as little 158 
interference as possible but maintaining a position to observe both the nurse(s) and patient. Hand-159 
written observation notes were taken by the researcher and typed up into full notes following the 160 
observation.  161 
 162 
Semi-structured interviews were conducted by JS and KL, with nurses and case and control patients. 163 
Topic guides were developed to reflect the objectives of the study by the study team, which included 164 
input by LW who has over 20 years of experience as a cardiovascular nurse, and also the study patient 165 
and public involvement group. Nurse topic guides focused on the nurse’s professional background, 166 
the training they received for the diagnostic accuracy study, their perspectives on ABPI and MPPG, 167 
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and thoughts on the future use of MPPG in primary care. Topic guides for control patients included 168 
the participant’s experience of being in the diagnostic accuracy study, their perspectives on ABPI and 169 
MPPG, and their preference for either test. Topic guides for case patients were the same, but also 170 
included questions on their PAD, including their history of PAD, the diagnosis of PAD, and how their 171 
PAD was being managed. Interviews were conducted at a time and place convenient to the participant, 172 
with only the researcher and participant present. For nurses, this was always during working hours at 173 
their primary care practice or by telephone. For patients, this was always during the day at their home 174 
or by telephone. All interviews were audio-recorded and transcribed verbatim by a third party 175 
transcription company. A researcher checked the transcriptions for accuracy.  176 
 177 
Data analysis 178 
Data were analysed using thematic analysis following the stages described by Braun and Clarke [30]. 179 
This included familiarisation with the data set by one researcher (JS), which was obtained from both 180 
collecting the data and reading transcripts. Initial inductive codes were then generated, using NVivo 181 
10 to catalogue the codes. Data analysis sessions were held, at which source data and the developing 182 
coding frame were discussed and refined by JS, JL, and NR. JS then generated the final themes, which 183 
were then discussed and refined further by JS, JL, and NR. Data from all sources was triangulated at 184 
the point of coding, with all data coded into the same themes. 185 
 186 
Validity and rigour 187 
Several established approaches were taken to ensure the validity and rigour of the findings [31], 188 
including development of a coding system, peer review of themes, triangulation of multiple data 189 
sources (nurse interviews, patient interviews and observations), and provision of thick description that 190 
recognises the context of data collection, supported by quotes and detailed field notes. Furthermore, 191 
the Consolidated criteria for reporting qualitative research (COREQ) checklist [32] was used to confirm 192 
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complete and transparent reporting of qualitative data, ensuring sufficient information is provided to 193 
determine transferability of findings.  194 
 195 
Ethical considerations 196 
Ethical and governance approvals were granted by an NHS Research Ethics Committee North East – 197 
Newcastle & North Tyneside 1 (ref: 14/NE/1238) and the MHRA (ref: CI/2015/0017). The trial was 198 
registered 13th October 2016 (ISRCTN ref: 13301188).  199 
 200 
Results 201 
Data were collected between June 2015 and September 2016 and included 51 observations of ABPI 202 
and MPPG in use at nine GP practices by 13 nurses. Twenty-nine observations were of case 203 
participants, and 22 were of control participants. Data also included semi-structured interviews with 204 
12 nurses, 17 case patients and ten control patients. Nurse interviews lasted between 16m 24s and 205 
34m 22s (average 26m 09s). Patient interviews lasted between 10m 01s and 36m 46s (average 18m 206 
44s).  207 
 208 
The findings are presented below according to the two major themes and their sub-themes identified 209 
in the analysis; (1) device preferences, and (2) test discomfort and anxiety. Selective representative 210 
quotes have been included. 211 
 212 
Device preferences 213 
The first major theme identified related to participants’ device preferences, in particular a compelling 214 
preference among nurses for MPPG over ABPI. This is despite the MPPG device that was tested not 215 
being feature-complete, including requiring manual adjustment of gains to take readings. Preference 216 
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for MPPG amongst both nurses and patients tended to be determined by four aspects; ease of use for 217 
nurses, speed of test, comfort, and perceived device accuracy and objectivity. These are succinctly 218 
summarised by one nurse:  219 
 220 
“I think the fact that [MPPG is] very quick, it can be done very quickly for the patients, 221 
it’s not as painful with the fact that you’re not blowing up the cuff on the patient, and 222 
sometimes when you’re using the Doppler [ultrasound] machine trying to find the 223 
pulse rate is really hard. I just think it’s very effective. If it’s proven that the data [from 224 
the study] is matching with the ABPI that we do, it just proves it’s a very effective 225 
piece of equipment. It’s easy to use. It’s easier for the patients and its pain free. It’s 226 
just a more pleasant experience for the patient.” (Nurse-3 interview) 227 
 228 
Ease of use for nurses 229 
All of the nurse participants that used ABPI and MPPG stated a preference for MPPG, often citing the 230 
ease of use. This largely related to the required dexterity of inflating the blood pressure cuff whilst 231 
simultaneously holding the Doppler ultrasound probe in place, where sometimes the smallest of 232 
movements would result in losing the required signal location. Nurses quickly became familiar with 233 
the device, despite it being a prototype design, and found it much easier to use than ABPI. 234 
 235 
“I initially thought the [prototype MPPG] machine was quite fiddly, just with all the 236 
leads. It looked, initially, quite frightening because of all the leads and stuff. But once 237 
you got to use it, it was just confidence I think, and practice with it. I found the MPPG 238 
machine more accurate and easier to use than the ambulatory blood pressure.” 239 
(Nurse-10 interview) 240 
 241 
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“During the break I talk to the nurse about how it was (doing the tests) with the first 242 
patient, the first time she’d done it. She says that the MPPG was much easier than 243 
the ABPI but she was expecting it the other way around. She thought there were more 244 
cables for MPPG than there actually are.” (Observation-12 field notes, 2nd 245 
participant) 246 
 247 
Device accuracy and objectivity 248 
Another reason given by nurses for preferring MPPG over ABPI was its perceived accuracy. Whilst at 249 
the time of data collection it was not known whether MPPG would be as accurate as ABPI, nurses still 250 
had more confidence in the device’s reliability, acknowledging that ABPI was to some extent 251 
subjective; “I think the Doppler is much more open to interpretation by the clinician.” (Nurse-2 252 
interview). This perception was not unique to nurses conducting the tests. In the following quote, a 253 
patient reflects on their experience of ABPI both within and prior to the diagnostic accuracy study 254 
setting.  255 
 256 
“I mean, if your new test [MPPG] proves to be accurate, I’d much prefer that than the 257 
Doppler. […] I mean, if you get a nurse that’s not fully qualified on the Doppler, she 258 
can miss the pulse, you know. Either by A, going in the wrong place or B, not being 259 
quite able to find it. If they’re going to use the Doppler [ABPI], perhaps there should 260 
be two tests like the previous one we just had [in the study]. You know, do one and 261 
then get perhaps somebody else to do another one or give you a break and then do 262 
it again to ensure that you’re actually getting an accurate reading.” (Patient-16 263 
interview, case) 264 
 265 
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Comfort 266 
As already identified, discomfort or pain was present for some patients whilst receiving the ABPI test, 267 
in particular when the blood pressure cuff was expanded on lower limbs. Knowing that MPPG was 268 
discomfort and pain free was also a contributing factor for nurses’ preference for MPPG, one of whom 269 
described it as “less invasive for the patient” (Nurse-10 interview), and also for patients’ preference 270 
for MPPG. Notably the following patient quote also presents uncertainty about their preference, 271 
which was relatively common amongst patients and is discussed in depth later in the results section. 272 
 273 
“Aye I don’t know. I mean having the, having the (MPPG) clips was, was no discomfort 274 
where I suppose you have a bit of discomfort with the cuffs but I don’t think there’s, 275 
you know, I don’t think I’d have a preference actually, as long as it was done that 276 
would be it. Yeah, I, I think the new one is possibly better, you know, the clips is 277 
possibly better ‘cause you don’t have the discomfort that you have with the, the 278 
cuffs.” (Patient-21 interview, case) 279 
 280 
Speed of test 281 
Both nurses and patients also recognised that MPPG was quicker, regardless of whether the rest 282 
period time was included or not. Notably, this preference was also clear even where (dis)comfort was 283 
not a contributing factor to a patient’s preference.  284 
 285 
“neither were uncomfortable and, but the one with the clips [MPPG] was quicker. So 286 
I suppose, I, I suppose the, the more modern version.” (Patient 6-interview, case) 287 
 288 
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“From the patients' point of view, lying for a long time is difficult for some people. So 289 
if it could be a shorter session where you have to lie flat, that would be an 290 
improvement for both of them.” (Nurse-11 interview) 291 
 292 
The use of the words “more modern version” by Patient-6 was also common amongst nurses when 293 
conducting the tests; in particular when introducing the devices, nurses were likely to describe MPPG 294 
as ‘the new bit of kit’ (Observation-2 field notes, 3rd participant) or variants of this.  295 
 296 
Preference uncertainty 297 
As outlined previously, some patients struggled to identify a preference during interviews, even when 298 
asked directly. When pressed to choose one or the other, they almost always favoured MPPG but 299 
found it difficult to explain why. This appeared to link into the previous finding that tests in general, 300 
even if they cause discomfort or pain, are “part and parcel of the procedure” (Patient-4 interview, 301 
control) and therefore as a patient they will do whatever is required of them, or “it’s entirely up to 302 
what the doctors want to do” (Patient-12 interview, control).  303 
 304 
“Well the [MPPG] clips was very easy. When, when the [ABPI cuff] pressure was on, 305 
one of my ankles, there was a little bit of pain. But really, I, I wouldn’t be too bothered 306 
whether it was either. You know, I wouldn’t be too bothered whichever it was.” 307 
(Patient-10 interview, case) 308 
 309 
There were also occasions when patients were unable to provide a preference at all, even when 310 
pressed by the interviewer. One patient was unable to differentiate between the procedure for ABPI 311 
and MPPG, suggesting they considered them to be a single event rather than multiple tests, “And the 312 
procedure for the new apparatus just seemed to be exactly the same as the bloody old one” (Patient-313 
5 interview, case). In later interviews with nurses who had conducted ABPI, they were asked if they 314 
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knew why some patients may have difficulty identifying a preference. Answers to this question 315 
supported the notion that tests were seen as a necessity, as exemplified by the following quote.  316 
 317 
“No, I can’t think of why they wouldn’t [have a preference]. I think maybe they just 318 
accept any test for what it is, so those people wouldn’t be bothered what test they 319 
did, as long as they get the result at the end and they’re able to do something about 320 
the result. They’re not entirely different really, it’s either laying there having a 321 
Doppler done or having probes on your ears, or ears and fingers and toes, you know, 322 
so they’re probably not that different.” (Nurse-12 interview) 323 
 324 
Test discomfort and anxiety 325 
The second major theme identified related to the relative levels of discomfort and anxiety experienced 326 
by both case and control participants whilst having the tests conducted.  327 
 328 
It was identified that requiring participants to lie flat, including the rest and test periods, caused 329 
discomfort amongst some patients, particularly as they were not routinely offered neck support. As 330 
data were collected during a diagnostic accuracy study rather than during natural use of either device, 331 
participants were required to lie down for longer than would be normal in order to accommodate 332 
both tests. Regardless of this prolonged period of lying flat, it was almost always immediately upon 333 
lying down that participants raised concerns. As a result, participants often requested to be sat 334 
upright, even if only partially, and study nurses were often hesitant of doing so due to concern that it 335 
would influence the results. Despite this, upon the requests, either the beds would be raised slightly, 336 
or participants would be provided with a pillow.  337 
 338 
‘One nurse asks the patient to lie down on the bed. Patient says she’ll struggle to lie 339 
completely flat and asks for her head to be raised – explains that she gets dizzy when 340 
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completely flat. The nurse raises the head part of the bed a small bit.’ (Observation-341 
11 field notes, 2nd participant) 342 
 343 
This discomfort was also acknowledged by nurses and patients during interviews. One nurse describes 344 
how the discomfort can be exacerbated by individual patient characteristics and the types of beds 345 
used in primary care: 346 
 347 
“The patients are required to lie completely flat and for some patients that can be 348 
very difficult and very uncomfortable.[…] the couches aren’t particularly well padded. 349 
And if the patients are overweight, or, you know, elderly, they have neck or spinal 350 
problems, it can be difficult for the patient” (Nurse-1 interview) 351 
 352 
“[Lying down] is something a few years ago, wouldn’t have been the slightest 353 
problem at all. But after a few minutes it became distinctly uncomfortable. So it, it’s 354 
difficult to straighten my legs, so there was pressure on my knee, trying to keep it 355 
straight, and across my shoulders. Because there was no head support, was the 356 
problem. However I just mentioned it to the nurse, ‘hey up,’ I says, I said, ‘this is 357 
uncomfortable,’ and so she just gave me a cushion for my head, and that was end of 358 
the problem.” (Patient-5 interview, case) 359 
 360 
This discomfort was not unique to either device within the diagnostic accuracy study context, as all 361 
patients were required to lie flat at all times. A second type of discomfort was also apparent in relation 362 
to ABPI, where the expansion of the blood pressure cuffs around lower limbs caused discomfort and, 363 
in several participants, pain. This was also reflected in interviews with nurses and patients, with one 364 
nurse reflecting on experiences of conducting ABPI prior to the diagnostic accuracy study: 365 
 366 
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“I think [ABPI is] a bit more uncomfortable for the patients as well, especially when it 367 
goes round their foot, round their leg. Especially if they’ve got high blood pressure 368 
‘cause you’re pumping it up quite high to, to get the beat come in and it’s… I’ve had 369 
a few patients in the past who have screamed” (Nurse-7 interview) 370 
 371 
There was no reported or observed difference in pain or discomfort between the case and control 372 
participants, and when asked, nurses were rarely aware of any discomfort or pain in specific patients, 373 
though some were aware it was a possibility. This was often because they were focusing on obtaining 374 
the correct reading, though they acknowledged the potential for pain or discomfort.  375 
 376 
‘When the nurse expands blood pressure cuff [on patient’s lower leg] the patient 377 
winces and takes a deep breath. The second time for the ankle reading, the patient 378 
also makes a noise from the pain. Nurses don’t appear to notice as they are 379 
concentrating on taking the readings’ (Observation-11 field notes, 1st participant) 380 
 381 
Despite the pain, patients were quick to dismiss it as a necessary part of healthcare, and rarely 382 
informed the nurse that the test was painful or uncomfortable. 383 
 384 
“Well when, once it gets tight, it’s, you feel a bit of discomfort but it only lasts seconds 385 
so it’s not too bad. It was quite, on the calves of the legs, it was quite painful. But as 386 
I say, it’s short term so, you know, it’s short term so it’s nothing to worry about” 387 
(Patient-21 interview, case) 388 
 389 
Beyond the physical discomfort, mental anxiety was evident in several patients. In particular, patients 390 
showed concern about the test readings when they did not go smoothly, such as a nurse being unable 391 
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to find the patient’s foot pulse during ABPI. Patients often shrouded this anxiety within a joke. In the 392 
following excerpt from field notes, the patient also raises concerns about their general health.  393 
 394 
‘Patient picks up that one of his [ABPI] readings is lower and starts asking about it. 395 
The research nurse tries to explain that it is normal, but he doesn’t seem to believe 396 
her; he keeps challenging and asking, ‘why?’’ (Observation-12 field notes, 4th 397 
participant) 398 
 399 
Due to the nature of the MPPG device assessed, where there is no indication of test outcome, most 400 
patients did not question the meaning of the test. Where few patients did, nurses explained that they 401 
themselves were unaware of the outcome. The same patient that continually questioned the research 402 
nurse over his ABPI readings later accepted, without further probing, that the nurse did not know the 403 
meaning of his MPPG results, ‘Patient asks what his ‘MPPG’ readings mean and nurse says she doesn’t 404 
know. Patient comments that every day is a training day’ (Observation-12 field notes, 4th participant).  405 
  406 
Discussion 407 
This is one of the first studies to use qualitative research methods to describe and compare 408 
preferences and experiences relating to ABPI and other non-invasive vascular tests for PAD diagnosis 409 
in primary care. This is despite qualitative methods being widely used in usability testing for various 410 
types of healthcare interventions [33 34], including imaging technologies [35]. ABPI is generally 411 
recognised to be a non-invasive and simple procedure [15 36], but we identified that ABPI is associated 412 
with a number of drawbacks in clinical practice that had not been identified previously, including pain 413 
and anxiety for patients, which contributed to an overwhelming preference for the MPPG PAD 414 
technology amongst the nurse and patient participants.  415 
 416 
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Notably, patients demonstrated or reported feelings of discomfort and pain during ABPI, which has 417 
not been explored in-depth previously in the literature, nor is it recognised as a limitation of ABPI 418 
within guidelines for PAD [12]. Some patients who experienced pain or discomfort in relation to the 419 
blood pressure cuff expansion appeared to be ambivalent; not only did they not highlight the pain or 420 
discomfort to the nurse conducting the test, but they also later explained that discomfort or pain was 421 
an expectation of medical testing, thus perceiving it to be a necessity to receiving a diagnosis [37]. This 422 
was emphasised when asked their preference for a device; many patients struggled to identify a 423 
preference without further prompting. Whilst there is evidence that invasive tests can impact on 424 
patient acceptance and participation, specifically when associated with pain and discomfort [38], 425 
there is a need for further research to usefully explore the meanings and experiences of patients 426 
undergoing routine non-invasive tests in primary care, especially where mild pain or discomfort is 427 
possible. This is of particular relevance for PAD, the symptoms of which are already under-reported [6 428 
7], and which could be influenced by test anxiety. 429 
 430 
The exception to this was where discomfort resulted from lying flat, with patients willing to inform 431 
the nurse in order to change their circumstances. One possible explanation for this willingness was 432 
that patients were able to anticipate their discomfort of lying down flat based on previous 433 
experiences, but, particularly in relation to blood pressure cuffs used on their lower limbs, were 434 
unlikely to have experienced the discomfort before. MPPG was perceived to be a quicker test to 435 
complete than ABPI, thus reducing the overall time required for patients to be lying down and being 436 
exposed to discomfort. Furthermore, nurses also failed to recognise when patients were in discomfort 437 
or pain, and so were unable to directly reassure patients or to perform ameliorating actions to reduce 438 
the discomfort or pain. Regardless of how patients justified experiencing pain, it is important to 439 
recognise that non-invasive tests, such as ABPI, are not pain-free, and patients should be informed of 440 
this potential a priori as part of the consent process.   441 
 442 
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For both ABPI and MPPG, patients sometimes queried the meaning of the test results even when the 443 
test was still being conducted. This was particularly evident during ABPI when either the dorsalis pedis 444 
or posterior tibial (foot) pulses were difficult or not possible to identify, either due to excessive 445 
claudication, the nurse’s ability with the device, or a combination of the two. Patients querying the 446 
test results during and immediately after the tests, particularly when a nurse was not qualified to 447 
provide a diagnosis, raises practical implications for both tests as it can place the nurse in an awkward 448 
position. For instance in practice, whilst the nurse may have a strong indication of the test result, it is 449 
not always likely that they have the full clinical picture, and are therefore unable to give the patient 450 
an answer. It has been identified that medical waiting periods require patients and clinicians to adopt 451 
coping strategies to ease patient anxiety [39 40]. One such strategy is preparative waiting, a part of 452 
which requires nurses to provide adjusted and individualised information to patients [41]. MPPG, in 453 
its prototype design used in this study, was able to obfuscate any identification of potential symptoms, 454 
allowing the test results to be analysed alongside the full clinical picture before being presented to 455 
the patient, therefore providing nurses with the opportunity to assist the patient with their coping 456 
strategies and reducing the potential for anxiety that has arisen during the test.  457 
 458 
A further drawback of ABPI which contributed to nurses’ preference for MPPG over ABPI was that 459 
ABPI required considerable dexterity to perform the test effectively. This is an identified barrier within 460 
the literature on ABPI, and has been reported to contribute to variations in measurement accuracy 461 
[42]. Furthermore, poor technique in performing ABPI in practice has been widely reported [20 42 43], 462 
and the high level of required dexterity contributed to the subjectivity that study participants 463 
associated with ABPI. MPPG was deemed to be a more objective measure as it was not liable to the 464 
same limitations, despite the actual device used in this study being a prototype. The ease of use of 465 
MPPG also potentially has further practical implications; it is likely to require less training and will not 466 
be subject to the same experiential learning curve of ABPI, and it can reduce the time required for 467 
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diagnosis, all of which may reduce the cost of implementation, though further evidence is required to 468 
determine whether it is more cost-effective than ABPI.  469 
 470 
Given the current challenges in diagnosing PAD, MPPG was reported by nurses to be easier and quicker 471 
to use, and appeared to cause less discomfort or pain in patients. MPPG may therefore help to reduce 472 
identified delays to diagnosis [6] and lead to greater uptake of formal diagnostic testing for PAD rather 473 
than the tendency to rely upon clinical symptoms [44]. MPPG may also help to reduce anxiety relating 474 
to negative test outcomes and could help to improve the patient’s experience of the diagnosis 475 
pathway, though additional formal evaluation of the final device will be required, which should include 476 
further examination of whether MPPG reduces test anxiety and therefore contributes to improved 477 
reporting of PAD symptoms.  478 
 479 
Limitations 480 
No standardised, validated measure of pain or discomfort was used, mainly because based on prior 481 
literature and NICE guidelines [12] they were not anticipated. Whilst this would have provided a 482 
quantifiable comparison between the two different tests, the evidence provided in this study was 483 
conclusive that ABPI resulted in more discomfort than MPPG, which was identified via numerous 484 
methods. However, future work (including trials of new medical devices) where discomfort may be 485 
expected should consider combining both quantitative and qualitative approaches to identifying and 486 
measuring pain or discomfort.  487 
 488 
Another limitation was that many of the participating nurses were not regular users of ABPI prior to 489 
involvement in this study, although all nurses regardless of prior ABPI experience received full training 490 
in the use of both techniques. This may partially explain the drawbacks identified with ABPI and the 491 
general preference for MPPG. However, this is not the first study to identify the dexterous nature of 492 
ABPI and the negative impact that this has on test outcomes [42], suggesting the results were not 493 
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artefacts of the study design. Furthermore, the nurses were novices in both devices, and so 494 
comparisons made were from an equal perspective.  495 
 496 
Finally, data was collected from participants who were taking part in a larger diagnostic study, and so 497 
the observations in particular are unlikely to full reflect actual experiences of using the two devices in 498 
practice. However, the tests were conducted as closely as possible to natural conditions, with patients 499 
seeing their own practice nurse in their own primary care practice. Particularly for MPPG, which used 500 
a prototype device design, further work will be required to determine the ease and speed of use of 501 
the device should it enter into routine practice, and to explore how it impacts upon the diagnosis 502 
pathway for PAD. Sampling for this qualitative study was based on recruitment to the clinical 503 
diagnostic accuracy study, and so demographic data was not collected beyond the patients’ PAD 504 
diagnosis.  505 
 506 
Conclusion 507 
This is one of the first studies to use qualitative approaches to investigate device preferences and 508 
experiences of using medical devices for PAD diagnosis in primary care. Whilst ABPI is a non-invasive 509 
and routine procedure, it is associated with a number of drawbacks in clinical practice. ABPI was found 510 
to cause discomfort and pain in some patients which is not currently acknowledged in national 511 
guidelines, and some patients experienced anxiety when a foot pulse was difficult or not possible to 512 
locate. In contrast, MPPG was deemed to be easier and quicker to use, and perceived to be less 513 
subjective. Should MPPG be at least comparable to ABPI in diagnostic specificity and sensitivity and 514 
with similar device costs, the results of this qualitative study suggest it would be preferable to ABPI 515 
for both patients and nurses. Further health technology evaluation of the final MPPG device is 516 
expected once implemented into practice on its pathway to adoption. 517 
 518 
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